-+ 0.00%
-+ 0.00%
-+ 0.00%

JMP Securities Reiterates Market Outperform on Haemonetics, Maintains $100 Price Target

Benzinga·05/20/2025 13:04:22
Listen to the news
JMP Securities analyst David Turkaly reiterates Haemonetics (NYSE:HAE) with a Market Outperform and maintains $100 price target.